Anticorps Monoclonal anti-m7G

m7G Monoclonal Antibody for IHC, Dot Blot, ELISA, Indirect ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

chemical compound

Applications

IHC, Dot Blot, ELISA, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

2C3E10

N° de cat : 68302-1-PBS

Synonymes

7-Methylguanosine



Informations sur le produit

68302-1-PBS cible m7G dans les applications de IHC, Dot Blot, ELISA, Indirect ELISA et montre une réactivité avec des échantillons chemical compound

Réactivité chemical compound
Hôte / Isotype Mouse / IgG2b
Clonalité Monoclonal
Type Anticorps
Immunogène Peptide
Nom complet m7G
Symbole du gène
Identification du gène (NCBI)
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

7-Methylguanosine (m7G) is a modified purine nucleoside. It is a methylated version of guanosine and when found in human urine, it may be a biomarker of some types of cancer. In the RNAs, 7-methylguanosine have been used to study and examine the reaction evolving methylguanosine. It also plays a role in mRNA as a blocking group at its 5´-end. The m7G modification actively participates in biological and pathological functions by affecting the metabolism of various RNA molecules, including messenger RNA, ribosomal RNA, microRNA, and transfer RNA. Increasing evidence indicates a critical role for m7G in human disease development, especially cancer, and aberrant m7G levels are closely associated with tumorigenesis and progression via regulation of the expression of multiple oncogenes and tumor suppressor genes.

Protocol for Dot Blot:
https://www.ptglab.com/protocol/68302-1-IgDotBlot.pdf

{{ptg:RelatedPrimaryAntibodies}}